Beacon’s Gene Therapy for Vision Loss Condition Meets Main Trial Goal

Beacon Therapeutics said on Monday its experimental gene therapy improved the ability to read ⁠in low-light conditions in a late-stage trial on people with a form of...
Reuters Health Information